πŸ›οΈ Verified NIH Record β€’ Updated 2025-09-29

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer (NCT05930210)

A Randomized, Double-Blind, Vehicle-controlled, Parallel, Phase III Study to Evaluate Efficacy and Safety of ENERGI-F703 GEL in Subjects With Diabetic Foot Ulcers

🟒 Recruiting Phase3 πŸ’Š Investigational Drug / Biologic Sponsor: Energenesis Biomedical Co., Ltd.

🩺 Plain-English Summary (8th-Grade Level)

This Phase 3 study is a randomized, double-blind, vehicle-controlled, multiple-center, parallel study to evaluate efficacy and safety of ENERGI-F703 GEL compared with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (\<16 cm2 vs β‰₯16 cm2 ) will be included as a stratification factor. Subjects will be randomized 1:1 to receive ENERGI-F703 GEL or vehicle control using an interactive web response system for randomization to automatically assign a unique subject randomization number. Total duration of the study will be up to 31 weeks including Screening visit (approximately 2 to 3 weeks), double-blind dosing/observation phase (16 weeks), and a safety follow-up of 12 weeks after the last administration of study treatment.

Who can join: Review the eligibility criteria below.

Location: A and D Doctor Center β€” Miami, Florida

Age range: 18 Years

πŸ§ͺ Interventions in This Study

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (24 Sites)

  • A and D Doctor Center β€” Miami, Florida
  • Bioclinical Research β€” Miami, Florida
  • Reliant Medical Research β€” Miami, Florida
  • Advanced Medical Research Institute β€” Miami, Florida
  • New Horizons Research β€” Palmetto Bay, Florida
  • IACT Health β€” Columbus, Georgia
  • The Jackson Clinic PA β€” Jackson, Tennessee
  • Mt. Olympus Medical Research β€” Houston, Texas
  • Wasatch Clinical Research β€” Salt Lake City, Utah
  • Salem Veterans Affairs Medical Center VAMC β€” Salem, Virginia
  • Ditmanson Medical Foundation Chia-Yi Christian Hospital β€” Chiayi City,
  • Kaohsiung Medical University Hospital β€” Kaohsiung City,
  • China Medical University Hospital β€” Taichung,
  • Kung Tien General Hospital β€” Taichung,
  • Taichung Veterans General Hospital β€” Taichung,
  • Chi Mei Medical Center β€” Tainan,
  • National Cheng Kung University Hospital β€” Tainan,
  • Cathay General Hospital β€” Taipei,
  • MacKay Memorial Hospital β€” Taipei,
  • National Taiwan University Hospital β€” Taipei,
  • Shin Kong Wu Ho Su Memorial Hospital β€” Taipei,
  • Taipei Veterans General Hospital β€” Taipei,
  • Tri-Service General Hospital β€” Taipei,
  • Linkou Chang Gung Memorial Hospital β€” Taoyuan,

πŸ“ž Contact the Study Coordinator

Phone: +886-2-26270835

Email: ct@energenesis-biomedical.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—